Leena . Tripathi 
,
Jaindra Nath Tripathi
For correspondence:- Leena Tripathi Email: l.tripathi@cgiar.org Tel:234-2-241-2626
Published: 17 December 2003
Citation: Tripathi L., Tripathi JN. Role of biotechnology in medicinal plants. Trop J Pharm Res 2003; 2(2):243-253 doi: 10.4314/tjpr.v2i2.9
© 2003 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Medicinal plants are the most important source of life saving drugs for the majority of the world’ s population. The biotechnological tools are important to select, multiply and conserve the critical genotypes of medicinal plants. In-vitro regeneration holds tremendous potential for the production of high-quality plant-based medicine.
Cryopreservation is long-term conservation method in liquid nitrogen and provides an opportunity for conservation of endangered medicinal plants. In-vitro production of secondary metabolites in plant cell suspension cultures has been reported from various medicinal plants. Bioreactors are the key step towards commercial production of secondary metabolites by plant biotechnology. Genetic transformation may be a powerful tool for enhancing the productivity of novel secondary metabolites; especially by Agrobacterium rhizogenes induced hairy roots. This article discusses the applications of biotechnology for regeneration and genetic transformation for enhancement of secondary metabolite production in-vitro from medicinal plants.
Archives
News Updates
Fulltext in PDF